Aberrant NLRP3 activation has been closely associated with a wide range of human disorders, including cardiovascular disease, neurodegeneration, metabolic dysfunction–associated steatohepatitis (MASH), non–small cell lung cancer (NSCLC), and endometriosis (4–8). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.